2026-07-10T15:57:14+00:00 2025-08-31 440160260 Forvis Mazars LLP One Oak Plaza Suite 300 Asheville NC 28801 990 2024-09-01 570660489 The Blood Connection Inc BLOO 8642555000 1099 Bracken Road Piedmont SC 29673 Delisa K English CEO & President 8642555000 2026-07-10 true true Amy Bibby P00445891 8282542254 2026-07-10 2024 2025-03-06 01:10:19Z Delisa K English 1099 Bracken Road Piedmont SC 29673 153423047 false X WWW.THEBLOODCONNECTION.ORG X 1979 SC PROVIDE COMMUNITY BLOOD BANKING & TRANSFUSION MEDICINE AND CELLULAR TRANSPLANTATION SERVICES. 13 13 1628 13 0 20191 56059 143925563 148843402 488299 761626 12520 11601 144446573 149672688 0 0 53793792 56241192 0 0 84636273 85113848 138430065 141355040 6016508 8317648 101949398 107707386 37175259 34362666 64774139 73344720 X HEALTHCARE PARTNERS SUPPORTED BY ADEQUATE, SAFE, COST-EFFECTIVE BLOOD SUPPLIES AND SERVICES. false false 95358967 148425685 BLOOD DONOR PROGRAM: ALLOGENEIC WHOLE BLOOD DONOR PROGRAM: AFFORDS FREE OPPORTUNITY FOR PATRONS TO PARTICIPATE IN COMMUNITY SERVICE IN THE FORM OF VOLUNTARY WHOLE BLOOD DONATIONS. FOR DONORS - EARLY DETECTION & TREATMENT OPPORTUNITY FOR HIGH BLOOD PRESSURE, ANEMIA, ABNORMAL PULSE RATE AND OTHER ILLNESSES FOUND DURING BLOOD DONOR SCREENING. AUTOLOGOUS BLOOD PROGRAM: AFFORDS FREE OPPORTUNITY FOR PATIENTS TO PROVIDE THEIR OWN BLOOD IN ADVANCE OF MEDICAL TREATMENT. REDUCTION IN DEMAND ON COMMUNITY BLOOD SUPPLY, REDUCED RISK OF TRANSFUSION TRANSMITTED DISEASE. DIRECTED BLOOD DONOR PROGRAM: AFFORDS OPPORTUNITY FOR PATIENTS TO DESIGNATE DONORS OF THE BLOOD FOR THE PATIENTS TRANSFUSIONS. AUTOMATED COLLECTION APHERESIS (PLATELET, PLASMA & RBC) DONOR PROGRAM: AFFORDS FREE OPPORTUNITY FOR PATRONS TO PARTICIPATE IN COMMUNITY SERVICE IN THE FORM OF VOLUNTARY, AUTOMATED DONATIONS. THERAPEUTIC SERVICE PROGRAM: PROVIDES FREE THERAPEUTIC PHLEBOTOMY FOR PATIENTS WITH BLOOD DISORDERS SUCH A POLYCYTHEMIA AND HEMOCHROMATOSIS. CELLULAR PROGRAM: HEMATOPOIETIC PROGENITOR CELL PROCESSING SERVICES: PROVIDES CELLULAR THERAPY SERVICES INCLUDING PROCESSING, CRYOPRESERVATION, STORAGE, INFUSION PREPARATIONS FOR IMMUNOTHERAPY, AND TRANSPLANT FOR BOTH AUTOLOGOUS AND MATCHED RELATED TRANSPLANTS FOR MULTIPLE MYELOMA, NHL AND HODGKINIS LYMPHOMA. PROVIDES TRANSPLANT PRODUCT PREPARATION AND SHIPMENT PREPARATION TO AN OUTSIDE FACILITY UPON REQUEST. THE CRYOGENIC STORAGE SERVICES ARE PROVIDED FREE OF CHARGE FOR THE FIRST YEAR. GOALS: PROCESS 100% OF REQUESTS FOR PROCESSING AND INFUSIONS OF HEMATOPOIETIC PROGENITOR CELLS AND DONOR LYMPHOCYTES, OFFER SERVICES 24/7, PROVIDE SAME DAY TURNAROUND FOR CD34+ FLOW CYTOMETRY ANALYSIS, AND PRODUCE A PRODUCT PROVEN TO BE CAPABLE OF ENGRAFTMENT. CELLULAR THERAPY COLLECTION SERVICES: PROVIDES CELLULAR COLLECTION SERVICES FOR TWO HEALTHCARE PROVIDERS. ONE, A BIOTECHNOLOGY COMPANY (DENDREON) APPLIES ITS EXPERTISE IN ANTIGEN IDENTIFICATION, ENGINEERING AND CELL PROCESSING TO PRODUCE AN ACTIVE CELLULAR IMMUNOTHERAPY PRODUCT CALLED PROVENGE (SIPULEUCEL-T). PROVENGE IS INDICATED FOR TREATMENT OF ASYMPTOMATIC OR MINIMALLY SYMPTOMATIC METASTATIC CASTRATE RESISTANT PROSTATE CANCER. THE BLOOD CONNECTION COLLECTS MONONUCLEAR CELLS FROM PROSTATE CANCER PATIENTS DEEMED SUITABLE BY THEIR PHYSICIAN AND SCHEDULED BY DENDREON. POST COLLECTION, THE COLLECTED PRODUCT IS SHIPPED TO DENDREON FOR FURTHER TESTING AND PROCESSING; THE FINAL PRODUCT IS LATER TRANSFUSED BACK TO THE PATIENT AT THEIR TRANSFUSION CENTER. THE OTHER PROVIDER IS A CANCER TREATMENT INSTITUTE AFFILIATED WITH A LOCAL HOSPITAL SYSTEM. THE BLOOD CONNECTION COLLECTS CIRCULATING BONE MARROW CELLS FROM PATIENTS IN THE REMISSION PHASE OF CELLULAR CANCERS SUCH AS LEUKEMIA, LYMPHOMA, AND MYELOMA. THOSE COLLECTIONS, RICH IN HEMATOPOIETIC PROGENITOR CELLS, ARE THEN PROCESSED AS DESCRIBED ABOVE. 19172934 SEE SCHEDULE O BLOOD PROCESSING STORAGE AND DISTRIBUTION: PROVISION OF BLOOD COMPONENTS TO HEALTHCARE PROVIDERS: ON A FEE FOR SERVICE BASIS, PREPARATION AND DISTRIBUTION OF BLOOD COMPONENTS TO HOSPITALS, CLINICS, DIALYSIS CENTERS, BLOOD BANKS, AND BLOOD FRACTIONATORS. GOAL: PREPARE BLOOD COMPONENTS AND DISTRIBUTE ACCORDING TO NEEDS OF HEALTHCARE CLIENTS. MAINTAIN CONSISTENT (5-7 DAY SUPPLY) INVENTORY OF ALL TYPES UNITS OF PLASMA DISTRIBUTED FOR BLOOD DERIVATIVE PREPARATION. COST CONTAINMENT FOR HEALTHCARE OF BLOOD COMPONENTS, FOR HEALTHCARE CLIENTS, NUMBER OF PATIENT BENEFICIARIES, DERIVED HEALTH BENEFITS, LIVES SAVED. 18024135 417717 SEE SCHEDULE O LABORATORY SERVICES: DONATED BLOOD TESTING PROGRAM: USES LABORATORY SEROLOGIC, CHEMISTRY, AND INFECTIOUS DISEASE ASSAYS TO ASSESS THE SUITABILITY OF DONATED BLOOD, PLATELETS AND PLASMA. FOR DONORS DETECTION OF INFECTIOUS DISEASE FOR WHICH DONOR MAY SEEK TREATMENT. POSITIVE PUBLIC HEALTH CONSEQUENCES OF DISEASE DETECTION, PARTNER NOTIFICATION, EXPOSURE CONTROL. 564467 ADDITIONAL PROGRAM EXPENSES INCLUDE INTEREST EXPENSES AND PROGRAM RELATED ADMINISTRATIVE EXPENSES. 564467 133120503 true true false true false false false false false false true false false true true true true false false false false false false false false false false false false true false false false false false false false false false false false false false false false false false false false false true 71 0 true 1628 true false false false false false false false false false false false false X 13 13 false false false false false false false true true false false false true true true true true true true true true true GA NC SC VA X Don Hall 8642555000 1099 Bracken Road Piedmont SC 29673 Ben Abzug Secretary 2.0 X X 0 0 0 Jessica McCoy Vice Chair 2.0 X X 0 0 0 Walker McSwain Chairperson 2.0 X X 0 0 0 Brent Odom Trustee 2.0 X 0 0 0 Chad Richards Trustee 2.0 X 0 0 0 Forrest Long Trustee 2.0 X 0 0 0 Heidi Phillips Trustee (term ended Dec 2024) 2.0 X 0 0 0 Jeff Brown Trustee 2.0 X 0 0 0 Kip Dillihay Trustee 2.0 X 0 0 0 Larry Gosnell Trustee 2.0 X 0 0 0 Lisa Landreth Trustee 2.0 X 0 0 0 Mark Johnston Trustee 2.0 X 0 0 0 Priscilla Cherry Trustee 2.0 X 0 0 0 Scott Pietras Trustee (term ended Dec 2024) 2.0 X 0 0 0 Surabhi Gaur Trustee 2.0 X 0 0 0 Delisa English PRESIDENT/CEO 40.0 X 541943 0 32619 Don Hall CFO 40.0 X 280472 0 62076 Amber Fuller Sr Director of Technical Services 40.0 X 164640 0 35760 Brian Madden Executive VP/COO 40.0 X 401040 0 40909 Denise Calloway VP/Chief Quality Officer 40.0 X 266576 0 27155 Latronya Rodgers VP of Clinical Support 40.0 X 206266 0 15833 Robert Rainer Medical Director 40.0 X 275774 0 17368 Ryan Horejsi Sr Director of HR 40.0 X 186395 0 21336 Theresa Botti Divisional Director II 40.0 X 167222 0 39423 Tracy Bridges Executive VP/Chief Technical Officer 40.0 X 319167 0 41059 Troy Kidd Divisional Director III 40.0 X 180269 0 27362 William Mimbs VP of Operational Support 40.0 X 217763 0 44039 Adam Medford Information Technology Manager 40.0 X 122224 0 22508 Christen Grazulis Director of Quality and Safety 40.0 X 127123 0 25030 Kenneth Hager Director of Production Planning 40.0 X 128264 0 35067 Michael McDaniel Donor Services Regional Director 40.0 X 135464 0 11117 Stephanie Ezell Director of Donor Resources 40.0 X 115870 0 19770 3836472 0 518431 21 false true false IT Synergistics LLC 26 Security Dr Jackson TN 38305 Software Services 633400 Execusource LLC PO Box 7971 Carol Stream IL 60197 Temp Agency 498849 Eagle Express of SC LLC PO Box 51583 Piedmont SC 29673 Courier Service 371957 CGR SBG FD LLC PO Box 51583 Piedmont SC 29673 Auto dealership 341218 ACDS Technology LLC 14 Hartman Rd Greer SC 29651 Tech Support Services 336098 14 56059 56059 Blood Service Fee 541380 146469024 146469024 Lab Testings 541380 417717 417717 Cellular Therapy 541380 843917 843917 1112744 1112744 0 0 148843402 620021 620021 11601 11601 0 11601 11601 3765000 126964 3640061 110298 124939 16666 141605 141605 0 0 0 0 0 149672688 148843402 0 773227 3910024 1104885 2805139 41673130 41368925 304205 2388819 2190251 198568 4984283 4064213 920070 3284936 3103649 181287 61883 61883 132748 75356 57392 69485 69485 4682793 4307055 375738 0 24156594 24156594 10015345 9447387 567958 728125 728125 1053131 962062 91069 3294336 3182299 112037 23939 17473 6466 545562 545562 5997224 5415772 581452 1582672 1582672 Risk Management 2011927 110139 1901788 Medical Supplies 30758084 30758084 0 0 0 0 141355040 133120503 8234537 0 1000 1000 6446101 3319955 34029 23741 24805658 23813935 0 0 0 0 722107 722107 3599258 3937846 2603612 2646298 90384940 46560149 42515112 43824791 10192907 15927910 0 462045 462045 1 10567568 13027758 101949398 107707386 10754671 9164775 73363 89637 0 0 15945956 12048634 10401269 13059620 37175259 34362666 X 64740110 73320979 34029 23741 64774139 73344720 101949398 107707386 8317648 263222 -10289 0 X false true true false X 3418670 7186 68394 20191 56059 3570500 95525381 97438178 117957746 143925563 148843402 603690270 0 0 0 98944051 97445364 118026140 143945754 148899461 607260770 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 607260770 236804 369736 309244 439914 631622 1987320 0 236804 369736 309244 439914 631622 1987320 0 0 0 0 0 0 0 99180855 97815100 118335384 144385668 149531083 609248090 0.99674 0.99732 0 0.0 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false false false false false false false false true 3050 3050 false Schedule C, Part II-B, Line 1 DETAILED DESCRIPTION OF THE LOBBYING ACTIVITY THE BLOOD CONNECTION PAID A VOTING MEMBERSHIP FEE TO AMERICA'S BLOOD CENTERS. A PORTION OF THIS MEMBERSHIP FEE IS USED FOR LOBBYING PURPOSES. THE ESTIMATED PORTION FOR THE YEAR WAS $3,050. 3786719 3786719 19975829 7942316 12033513 8503525 3380970 5122555 58118867 35236863 22882004 43824791 Interest Receivable 55356 Sales Tax Receivable 151518 Interest Rate Swap 346701 Right-of-Use Asset 12474183 13027758 Federal Income Taxes Right-of-use Liability 13059620 13059620 X 149869802 263222 3377 0 266599 149603203 69485 0 69485 149672688 141299221 13666 0 13666 141285555 69485 0 69485 141355040 Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote The Blood Connection has been recognized by the Internal Revenue Service as exempt from income taxes under IRC Section 501(c)(3) and, consequently, also is recognized as a tax-exempt organization by the South Carolina Tax Commission. Accordingly, the accompanying financial statements do not reflect a provision or liability for federal and state income taxes. The Blood Connection determined that there are no material unrecognized tax benefits or obligations as of August 31, 2025 or 2024. X false true X X X X X X false false false false false true false false false Delisa English PRESIDENT/CEO 416770 0 109150 0 16023 0 30232 0 2387 0 574562 0 0 0 Don Hall CFO 235855 0 44617 0 0 0 28683 0 33393 0 342548 0 0 0 Brian Madden Executive VP/COO 308014 0 63500 0 29526 0 30907 0 10002 0 441949 0 0 0 Tracy Bridges Executive VP/Chief Technical Officer 242511 0 49617 0 27039 0 31057 0 10002 0 360226 0 0 0 Denise Calloway VP/Chief Quality Officer 208810 0 47057 0 10709 0 16314 0 10841 0 293731 0 0 0 Robert Rainer Medical Director 254734 0 21040 0 0 0 9646 0 7722 0 293142 0 0 0 William Mimbs VP of Operational Support 175916 0 36870 0 4977 0 20606 0 23433 0 261802 0 0 0 Latronya Rodgers VP of Clinical Support 162525 0 35777 0 7964 0 14599 0 1234 0 222099 0 0 0 Ryan Horejsi Sr Director of HR 168998 0 13805 0 3592 0 19049 0 2287 0 207731 0 0 0 Troy Kidd Divisional Director III 159999 0 13010 0 7260 0 18224 0 9138 0 207631 0 0 0 Theresa Botti Divisional Director II 154212 0 13010 0 0 0 17301 0 22122 0 206645 0 0 0 Amber Fuller Sr Director of Technical Services 152090 0 12550 0 0 0 14065 0 21695 0 200400 0 0 0 Kenneth Hager Director of Production Planning 118124 0 9668 0 472 0 13441 0 21626 0 163331 0 0 0 Christen Grazulis Director of Quality and Safety 117259 0 9864 0 0 0 8053 0 16977 0 152153 0 0 0 Schedule J, Part I, Line 1a Health or social club dues or initiation fees THE ORGANIZATION PROVIDES THE OFFICERS WITH MEMBERSHIP TO THE COMMERCE CLUB OR POINSETT CLUB. Schedule J, Part I, Line 6a Compensation contingent on net earnings of the organization NET REVENUE SHARING ARRANGEMENT (PRIDE PROGRAM) All eligible employees participate in the net revenue sharing arrangement. Criteria have been set and are measured on a monthly basis to determine the amount available for distribution. The criteria are reviewed for accuracy and consistency before the distribution is made. Caps are in place to provide guidance on the maximum amount that an employee can earn under the agreement. Participation is open to all employees that meet basic eligibility requirements. Based on services obtained from compensation consultants in the past, the distribution amounts are reasonable in comparison to industry norms. Calculation of the distribution amount includes retaining 50% of the excess net revenue for the organization to protect against disproportional benefits to the employees at the expense of the organization. The CEO has an incentive plan based on 5 company performance criteria. This plan has been put in place by the Board. Form 990, Part III, Line 4d Description of other program services (Expenses $ 564,467 including grants of $) ADDITIONAL PROGRAM EXPENSES INCLUDE INTEREST EXPENSES AND PROGRAM RELATED ADMINISTRATIVE EXPENSES. Form 990, Part VI, Line 18 THE ORGANIZATION MAKES ITS 990 AVAILABLE TO THE PUBLIC UPON REQUEST. Form 990, Part VI, Line 11b Review of form 990 by governing body AN ELECTRONIC COPY OF THE FORM 990 WAS PROVIDED TO THE FINANCE COMMITTEE FOR THEIR REVIEW AND APPROVAL. AFTER THE FINANCE COMMITTEE'S REVIEW, ALL TRUSTEES RECEIVED AN ELECTRONIC COPY FOR THEIR REVIEW PRIOR TO THE RETURN'S FILING. Form 990, Part VI, Line 12c Conflict of interest policy EACH BOARD MEMBER AND KEY EMPLOYEE IS PROVIDED A COPY OF THE CONFLICT OF INTEREST POLICY AND SIGNS A STATEMENT ANNUALLY TO DOCUMENT THE RECEIPT OF THE POLICY, READING AND UNDERSTANDING THE POLICY, AND DISCLOSING ANY POTENTIAL CONFLICTS OF INTEREST THROUGH ANSWERING A RELATED SET OF QUESTIONS. AT THE BEGINNING OF EACH BOARD MEETING, MEMBERS ARE ASKED TO DISCLOSE ANY POTENTIAL CONFLICT OF INTEREST BASED ON THE AGENDA SET FOR THE MEETING. IF A POTENTIAL CONFLICT IS IDENTIFIED, THE BOARD DETERMINES WHETHER A CONFLICT EXISTS AND FOLLOWS THE POLICY TO HANDLE IT. Form 990, Part VI, Line 15a Process to establish compensation of top management official COMPENSATION FOR THE CEO IS SET BY THE PERSONNEL COMMITTEE AND APPROVED BY THE BOARD. Form 990, Part VI, Line 15b Process to establish compensation of other employees COMPENSATION FOR THE EXECUTIVE VP/COO, EXECUTIVE VP/CHIEF TECHNICAL OFFICER, AND CFO IS SET BY THE CEO. COMPARABILITY DATA IS USED TO DETERMINE COMPENSATION AND INCLUDES REVIEW OF 990S FROM SIMILAR ORGANIZATIONS, REVIEW OF COMPENSATION DATA FOR SIMILAR POSITIONS FROM AN INDEPENDENT PARTY AND BLOOD CENTER INDUSTRY DATA, AND REVIEWS OF COMPENSATION PRACTICES BY INDEPENDENT CONSULTANT. Form 990, Part VI, Line 19 Required documents available to the public THE ORGANIZATION DOES NOT CURRENTLY MAKE ITS CONFLICT OF INTEREST POLICY OR GOVERNING DOCUMENTS AVAILABLE FOR PUBLIC INSPECTION. Form 990, Part VIII, Line 2f Other Program Service Revenue other program service revenue - Total Revenue: 1112744, Related or Exempt Function Revenue: 1112744, Unrelated Business Revenue: , Revenue Excluded from Tax Under Sections 512, 513, or 514: ; Form 990, Part XII, Line 2c THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.